Alcidion Group Limited (ALC) is a Company that is engaged in the development and licensing of its healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its partners and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in Australia, New Zealand and the United Kingdom.
Find out what a historical investment in Alcidion Group would be worth today using our ALCDA stock calculator.
Buying ALCDA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Alcidion Group in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in ALCDA
What is the ticker symbol of Alcidion Group?
The ticker symbol for Alcidion Group is ALCDA.
How much is one share of ALCDA?
One share of ALCDA is valued at $1.27 as of 20 November 2026.
What is the market capitalisation of Alcidion Group ALCDA?
As of 20 November 2026 Alcidion Group has a market cap of $15.52M.
What is the P/E ratio of ALCDA?
The Price to Earnings ratio of ALCDA is 714.71.
What is the Earnings Per Share of ALCDA?
The Earnings Per Share of ALCDA is $0.00.
What is the 52-week high for Alcidion Group stock?
The Alcidion Group 52-week high stock price is $1.45.
What is the 52-week low for Alcidion Group stock?
The Alcidion Group 52-week low stock price is $0.83.
Can I buy ALCDA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ALCDA shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.